Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval

Oncogene

Volumn 13, Issue 11, 1996, Pages 2483-2485

  Rosenberg, Jonathan E ^a   Lisle, David K ^a   Burwick, Jennifer A ^a   Ueki, Keisuke ^a   Von Deimling, Andreas ^b   Mohrenweiser, Harvey W ^c   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Chromosome 19; D19S745; Glioma; Tumor suppressor gene

Indexed keywords

DNA MARKER; MICROSATELLITE DNA;

ARTICLE; ASTROCYTOMA; CANCER GENETICS; CHROMOSOME 19Q; DNA POLYMORPHISM; GENE DELETION; GENE MAPPING; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GLIOMA; HUMANS; POLYMORPHISM, GENETIC;

EID: 0030444184     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ashworth LK, Batzer MA, Brandriff B, Branscomb E, de Jong P, Garcia E, Games JA, Gordon LA, Lamerdin JE, Lennon G, Mohrenweiser H, Olsen AS, Slezak T and Carrano AV. (1995). Nature Genet., 11, 422-427.
2. Durocher F, Morissette J, Dufort I, Simard J and Luu-The V. (1995). Genomics, 29, 781-783.
3. Elbein SC, Hoffman M, Ridinger D, Otterud B and Leppert M. (1994). Diabetes, 43, 1061-1065.
4. Gordon LA, Bergmann A, Christensen M, Danganan L, Lee DA, Ashworth LK, Nelson DO, Olsen AS, Mohrenweiser HW, Carrano AV and Brandriff BF. (1995). Genomics, 30, 187-192.
5. Kleihues P, Burger PC and Scheithauer BW. (1993). Histological Typing of Tumours of the Central Nervous System. Springer-Verlag: Berlin.
6. Kraus JA, Koopman J, Kaskel P, Maintz D, Brandner S, Louis DN, Wiestler OD and von Deimling A. (1995). J. Neuropathol. Exp. Neurol., 54, 91-95.
7. Louis DN and Gusella JF. (1995). Trends Genet., 11, 412-415.
8. Louis DN, von Deimling A and Seizinger BR. (1992). Am. J. Pathol., 141, 777-782.
9. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP. (1994). Am. J. Pathol., 145, 1175-1190.
10. Rubio M-P, Correa KM, Ueki K, Mohrenweiser HW, Gusella JF, von Deimling A and Louis DN. (1994). Cancer Res., 54, 4760-4763.
11. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W, Emanuel B, Ponder B, Naylor S, Mitelman F, Louis DN, Menon A, Newsham I, Decker J, Kaelbing I, Henry I and von Deimling A. (1991). Cytogenet. Cell Genet., 58, 1080-1096.
12. von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG, Louis DN, Lenartz D, Schramm J and Wiestier OD. (1994). Cancer Res., 54, 1397-1401.
13. von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestier OD and Seizinger BR. (1992). Cancer Res. 52, 4277-4279.
14. von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN and Weistler OD. (1994). Int. J. Cancer, 57, 676-680.
15. Yong WH, Chou D, Ueki K, Harsh GR, von Deimling A, Gusella JF, Mohrenweiser HW and Louis DN. (1995a). J. Neuropathol. Exp. Neurol., 54, 622-626.
16. Yong WH, Ueki K, Chou D, Reeves SA, von Deimling A, Gusella JF, Mohrenweiser HW, Buckler AJ and Louis DN. (1995b). Genomics, 29, 533-536.